<p>Eligible patient population and bevacizumab treatment schedules in 4 peer-reviewed RCTs.</p
<p>Number of people screened and patients treated according to NGO and period of intervention.</p
<p>Study population in the azithromycin-oseltamivir combination therapy and oseltamivir monotherapy ...
The number of available subjects in each diagnostic group for annual follow-up visits.</p
<p>Selection process for randomised controlled trials on the effects of ranibizumab and bevacizumab ...
<p>Demographic characteristics of the 10,278 patients in the study population by calendar time of tr...
<p>Patient recruitment algorithm for antiretroviral therapy experienced patients screened for the 20...
<p>Number of trials and individual eligibility criteria in our 4 data sets and the date of data retr...
Distribution of study population according to eligibility at entry into care or later, treatment ini...
<p>TNF, tumor necrosis factor.</p><p>Number of patients according to the course of treatment.</p
<p>pCR (95% Cl) for evaluation the use of bevacizumab in neoadjuvant treatment.</p
Selection of the study population and distribution according to eligibility at entry into care or la...
<p>Determination of timely follow-up CD4 cell count testing by demographic and baseline treatment va...
<p>Demographic characteristics of patients randomized to boceprevir and telaprevir.</p
<p>Number indicates the number of therapies used (a single subject may have had more than one therap...
<p>Patient enrolment in the antiretroviral treatment service and outcomes during follow-up.</p
<p>Number of people screened and patients treated according to NGO and period of intervention.</p
<p>Study population in the azithromycin-oseltamivir combination therapy and oseltamivir monotherapy ...
The number of available subjects in each diagnostic group for annual follow-up visits.</p
<p>Selection process for randomised controlled trials on the effects of ranibizumab and bevacizumab ...
<p>Demographic characteristics of the 10,278 patients in the study population by calendar time of tr...
<p>Patient recruitment algorithm for antiretroviral therapy experienced patients screened for the 20...
<p>Number of trials and individual eligibility criteria in our 4 data sets and the date of data retr...
Distribution of study population according to eligibility at entry into care or later, treatment ini...
<p>TNF, tumor necrosis factor.</p><p>Number of patients according to the course of treatment.</p
<p>pCR (95% Cl) for evaluation the use of bevacizumab in neoadjuvant treatment.</p
Selection of the study population and distribution according to eligibility at entry into care or la...
<p>Determination of timely follow-up CD4 cell count testing by demographic and baseline treatment va...
<p>Demographic characteristics of patients randomized to boceprevir and telaprevir.</p
<p>Number indicates the number of therapies used (a single subject may have had more than one therap...
<p>Patient enrolment in the antiretroviral treatment service and outcomes during follow-up.</p
<p>Number of people screened and patients treated according to NGO and period of intervention.</p
<p>Study population in the azithromycin-oseltamivir combination therapy and oseltamivir monotherapy ...
The number of available subjects in each diagnostic group for annual follow-up visits.</p
DOI
Add to ORKG